Stay updated on CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial

Sign up to get notified when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T19:59:12.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning to use “Super Intelligence” in place of “Artificial Intelligence,” and directs visitors to related updates and FAQs.
    Difference
    0.6%
    Check dated 2026-10-24T22:20:32.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T22:19:20.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The site revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T22:17:22.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The study history UI now shows a standardized 'Find contact information' label and the latest revision tag (v3.7.0). This replaces the previous capitalization ('Find Contact Information') and the older tag (v3.6.6).
    Difference
    0.2%
    Check dated 2026-09-19T22:22:11.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    An updated revision entry 'v3.6.6' is now listed in the record history, replacing the previous 'v3.6.5'. This reflects a metadata update to the study record rather than a substantive study content change.
    Difference
    0.1%
    Check dated 2026-08-29T18:43:13.000Z thumbnail image

Stay in the know with updates to CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.